ePlus vs ScanSource
PLUS and SCSC side by side, both in professional and commercial equipment and supplies. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How PLUS and SCSC compare
ePlus is the larger company, worth 2.8 times as much as ScanSource ($2.5B against $900M).
On earnings, ScanSource is cheaper: it trades at 14.0× trailing earnings, against 19.4× for ePlus.
ScanSource grew revenue faster over the last twelve months (14.8% versus 13.1% for ePlus).
ePlus keeps more of each dollar of sales as profit, with a net margin of 5.2% compared with 2.0% at ScanSource.
ePlus pays a dividend yielding 1.1%; ScanSource does not pay one.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | PLUS | SCSC |
|---|---|---|
| Size and price | ||
| Market cap | $2.5B | $900M |
| Share price | $97.19 | $44.69 |
| Change, 1 year | 10.1% | 8.2% |
| Change, 5 years | 68.9% | 32.8% |
| Beta (5Y) | 0.99 | 1.15 |
| Employees | 2,148 | 2,100 |
| StockData Score | ||
| Total score | 14 | 14 |
| Valuation score | 1 | 4 (better) |
| Growth score | 0 | 2 (better) |
| Performance score | 4 (better) | 2 |
| Health score | 6 | 6 |
| Dividend score | 3 (better) | 0 |
| Valuation | ||
| P/E | 19.4× | 14.0× (better) |
| P/S | 1.0× | 0.3× (better) |
| P/B | 2.3× | 1.0× (better) |
| EV/EBITDA | 10.7× | 8.7× (better) |
| P/FCF | 80.3× | 18.4× (better) |
| PEG | 4.94 (better) | 15.02 |
| FCF yield | 1.2% | 5.4% (better) |
| Fair value | $86.06 | $57.91 |
| Margin of safety | −12.9% | 22.8% (better) |
| Growth | ||
| Revenue growth (TTM) | 13.1% | 14.8% (better) |
| Revenue growth, 5Y average | 9.3% (better) | 0.47% |
| Net income growth (TTM) | 6.0% (better) | −9.1% |
| EPS growth (TTM) | 7.3% (better) | −0.62% |
| EPS growth, 5Y average | 12.7% | 54.0% (better) |
| Profitability | ||
| Gross margin | 25.4% (better) | 13.0% |
| Operating margin | 7.0% (better) | 2.5% |
| Net margin | 5.2% (better) | 2.0% |
| FCF margin | 1.3% | 1.4% (better) |
| Return on equity | 12.2% (better) | 7.4% |
| Return on invested capital | 18.7% (better) | 6.9% |
| Financial health | ||
| Debt / equity | 0.00 | 0.11 (better) |
| Net debt / EBITDA | – | 0.50 |
| Interest coverage | – | 11.0× |
| Current ratio | 1.99 (better) | 1.75 |
| Altman Z-score | 4.44 (better) | 3.08 |
| Piotroski F-score | 6 | 8 (better) |
| Dividends and buybacks | ||
| Dividend yield | 1.1% | – |
| Payout ratio | 20.8% | – |
| Years of dividend growth | 0 | – |
| Buyback yield | 2.3% | 9.0% (better) |
| Shareholder yield | 3.4% | 9.0% (better) |
| Ownership | ||
| Held by institutions | 96.6% | 107% |
| Held by insiders | 2.1% | 3.1% |
| Insider net buying, 12 months | −$2.3M (better) | −$7.2M |
| Short interest, % of float | 5.7% | 6.9% |
Go deeper
- PLUS stock overview
- PLUS income statement
- PLUS valuation and score
- SCSC stock overview
- SCSC income statement
- SCSC valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.